Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Cingulate Inc.

NASDAQ: CING · Life Sciences · 4 alerts · CIK 1862150

Share price
$3.75Close, Nov 16
Market cap
$56.1M
Shares outstanding
14.96MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Cingulate Inc. filings on SEC EDGAR ↗

8:10 AM ET 8-K
Business Update

Cingulate Business Update

Cingulate Inc. provided a regulatory update on its lead ADHD asset, CTx-1301, following a previously received FDA Complete Response Letter (CRL). The company has substantially completed the required manufacturing work to address the FDA's requests and expects to resubmit its New Drug Application (NDA) between December 2026 and January 2027.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.